FDA
approval
· 2019-05-20
FDA Approved: SOLIFENACIN SUCCINATE — Original Application (ScieGen Pharmaceuticals, Inc.)
Summary
FDA approves the original application for solifenacin succinate (generic) for overactive bladder, supplied by ScieGen Pharmaceuticals, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SOLIFENACIN SUCCINATE (SOLIFENACIN SUCCINATE)